MannKind Articles

MannKind sells cancer drug rights to Colby; Forest licensing deal with Adamas

15 November 2012

MannKind licenses novel BTK inhibitors to Tolero Pharma

1 May 2012

MannKind shares plummet as FDA delays Afrezza, calling for more trials

21 January 2011

US marketing delay for MannKind’s Afrezza and Cephalon drops Nuvigil for jet lag

4 January 2011

Good news for MannKind as US FDA accepts firm’s response on Afrezza

26 July 2010

MannKind shares jump on positive data for diabetes drug Afrezza

11 June 2010

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end